SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > Regulatory & Safety

Read more breaking news

 

 

Interactive map of fiscal 2011 FDA cGMP warning letters

By Nick Taylor , 26-Apr-2012
Last updated on 26-Apr-2012 at 10:06 GMT

In-PharmaTechnologist presents an interactive map showing the global distribution of US FDA cGMP warning letters in fiscal 2011.

As reported earlier this week, the US Food and Drug Administration (FDA) continued to crackdown on overseas manufacturing plants last fiscal year with a 40 per cent increase in warning letters.

Sites in Mexico and India accounted for one-third of overseas production plants cited in FDA cGMP (current good manufacturing practice) warning letters last year. The map below shows the sites of these production plants and every other facility named by the FDA in fiscal 2011 warning letters.

North America and Western Europe account for many of the warning letters. For the first time since 2009 the FDA sent no warning letters to facilities in South America, leaving India and China as the emerging market hotbeds of regulatory enforcement actions.


View Warning Letters 2011 in a larger map

Related products

Key Industry Events

 

Access all events listing

Our events, Events from partners...

Products

Solid Lipid Excipients: Born to be Extruded !
Gattefossé Pharma
USP<233> Elemental Impurities Sample Prep Strategy
SGS Life Science Services
Online Cell Density Monitoring
Hamilton Bonaduz AG
Residual moisture in lyophilized pharmaceuticals
Metrohm – customized analysis for the pharmaceutical industry
Need help to bring insoluble APIs to the market?
Dow Pharma & Food Solutions